Skip to main content
  • COMPARISON OF NEW DRUG APPROVAL PROCEDURES AND REGULATORY STRUCTURES IN TURKEY AND CANADA

    About Authors:
    Abhisek Shukla*, Dr. Valluru Ravi
    Pharmaceutical Regulatory Affairs group, Dept. of Pharmaceutics,
    JSS College of Pharmacy, JSS University,
    Sri Shivarathreeshwara Nagar, Mysore-570015, Karnataka, India.
    abhishekjsscp@gmail.com

  • A POTENTIAL MEDICINAL HERB: CORDYCEPS SINENSIS

    About Author:
    Buddhi Bal Chidi
    Department of Pharmacy,
    Maharajgunj Medical Campus, Institute of Medicine,
    Tribhuvan University, Kathmandu, Nepal
    buddhibal_chidi@iom.edu.np

  • A REVIEW : SELECTION OF DISSOLUTION MEDIA

    ABOUT AUTHOR:
    Mr. Ripal Mistry
    M.pharm, Indubhai Patel College Of Pharmacy & Research Center,
    Dharmaj
    Rx.ripalmistry@gmail.com

    DEFINATION:

  • CHRONIC MUCUS HYPERSECRETION AND CHRONIC OBSTRUCTIVE LUNG DISEASE THE MOST DISABLING HEALTH EFFECTS OF TOBACCO

    About Authors:
    Chinedu Enegide*, Mr. Kennedy I. Amagon
    Department of Science Lab. Tech.
    (Physiology/Pharmacology Tech.),
    University of Jos, Nigeria
    chinex.snow@gmail.com

    Abstact
    The use of tobacco have been in existence for long and have also been widely abused. Tobacco is now the leading cause of preventable death in the world today. An estimate of more than 5 million deaths  are recorded world-wide, yearly. Prediction also shows that deaths caused by tobacco may escalate to about 8 million by 2030. Statistics have shown that one out of every five deaths annually is caused by cigarette smoking. This statistics reveals about 440,000 smoking-related deaths yearly, and about 49,000 of these deaths are due to passive smoking. Both voluntary and involuntary (passive) smokers are at risk of the effects of tobacco. The effects of tobacco includes increased stress, alteration of brain cells chemistry, alteration of lipid profile, facilitation of atherosclerosis, increase in heart-rate and blood pressure, gastroesophageal reflux disease, peptic ulcer disease, micro-nutrient disorders, oxidtive damage, bronchospasm, chronic mucus hypersecretion and chronic obstructive lung disease. But however, chronic mucus hypersecretion and chronic obstructive lung disease stands out to be the most disabling effect of tobacco. As these effects are known to reduce one's physical performance, breathing capacity as well as fitness (both present and future). It is therefore advised that better measures for controlling tobacco usage especially in public places should be employed. As this will help to reduce the treat it currently posess on public health (especially the high rate of chronic mucus hypersecretion and chronic obstructive lung disease occurrence caused by tobacco).

  • METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS DETECTION BY PCR

    About Author:
    Mariz Sintaha
    Lecturer,
    School of Life Sciences
    Independent University, Bangladesh
    sintu.bmb@gmail.com

  • ROLE OF ANTIOXIDANT IN CANCER TREATMENT: A REVIEW

    About Authors:
    Dhakar Mukesh*, M. Jeevan, Kumar Neeraj, Dashora Ashok
    Geetanjali Institute of Pharmacy,
    (Department of Pharmaceutical Chemistry.)
    AirPort Road, Dabok, Udaipur (Rajasthan)- 313022
    *dhakarmukesh03@yahoo.com

  • PROSTAGLANDIN A USEFUL STRATEGY FOR NEW DRUG DEVELOPMENT: A REVIEW

    ABOUT AUTHORS:
    S.P.Sethy*1, P.Mishra2, T.Sameena1, P.Patil1, K.Shailaja1
    *1Department Of Pharmaceutical Chemistry, Sushrut Institute of pharmacy
    Taddanpally (V), Pulkal (M), Medak Dist-502273
    2Department Of Pharmacology.
    Malla Reddy College Of Pharmacy, Maisamaguga,
    Dhulapalli, Secunderabad-14

  • EVALUATION OF ANTIOXIDANT ACTIVITY OF FICUS GLOMERATA FRUIT

    About Authors:
    Gurvinder Pal Singh
    Senior Lecturer, Department of Pharmacognosy,
    Adesh Polytechnic College, Sri Muktsar Sahib, Punjab
    gp_singh352000@yahoo.com

  • NATURAL POLYMERS USED IN FLOATING DRUG DELIVERY SYSTEM

    ABOUT AUTHOR:
    Jeevan Menaria*, Rahul Kumar Garg, Dr. Ashok Dashora
    Geetanjali Institute Of Pharmacy,
    Udaipur 313001
    *jeevanmenaria@gmail.com

  • GLIPTINS: BETTER APPROACH FOR TYPE 2 DIABETES

    About Author:
    Parul Lal
    Product Manager
    Sapient Laboratories PVT. LTD
    parullal2011@gmail.com

Subscribe to Articles